Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6419)
All Articles published online
|
Publishing Process of This Article
|
Mar 28, 2014 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Golovics PA, Mandel MD, Lovasz BD, Lakatos PL. Inflammatory bowel disease course in Crohn’s disease: Is the natural history changing? World J Gastroenterol 2014; 20(12): 3198-3207 [PMID: 24696605 DOI: 10.3748/wjg.v20.i12.3198] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i12/3198.htm |
| Number | Citing Articles |
| 1 |
Shannon Chang, Bo Shen. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications. 2018; : 17 doi: 10.1016/B978-0-12-811388-2.00002-6
|
| 2 |
Abdulkader Mohammed Albasri. Histopathological Profile of Benign Colorectal Diseases in Al-Madinah Region of Saudi Arabia. Asian Pacific Journal of Cancer Prevention 2014; 15(18): 7673 doi: 10.7314/APJCP.2014.15.18.7673
|
| 3 |
David T. Rubin, Lauren D. Feld, Sarah R. Goeppinger, Joel Margolese, Joel Rosh, Michele Rubin, Sandra Kim, Dylan M. Rodriquez, Laura Wingate. The Crohnʼs and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access. Inflammatory Bowel Diseases 2017; 23(2): 224 doi: 10.1097/MIB.0000000000000994
|
| 4 |
Aditi Kumar, Alexander Cole, Jonathan Segal, Philip Smith, Jimmy K. Limdi. A review of the therapeutic management of Crohn’s disease. Therapeutic Advances in Gastroenterology 2022; 15: 175628482210784 doi: 10.1177/17562848221078456
|
| 5 |
Fan Dong, Ivana Kern, Jens Weidner, Kathleen Kügler, Ulrike Rothe, Makan Amin, Martin W. Laaß, Gunter Flemming, Ulf Winkler, Thomas Richter, Joachim Kugler, Ulf Manuwald, Mathilde Body-Malapel. Clinical course of new-onset Crohn’s disease in children and adolescents in dependency of age, initial location, initial severity level and therapy over the period 2000–2014 based on the Saxon Pediatric IBD-Registry in Germany. PLOS ONE 2023; 18(6): e0287860 doi: 10.1371/journal.pone.0287860
|
| 6 |
Choong Wui Cho, Myung-Won You, Chi Hyuk Oh, Chang Kyun Lee, Sung Kyoung Moon. Long-term Disease Course of Crohn’s Disease: Changes in Disease Location, Phenotype, Activities, and Predictive Factors. Gut and Liver 2022; 16(2): 157 doi: 10.5009/gnl210118
|
| 7 |
Eduard Brunet-Mas, Belen Garcia-Sagué, Emli Vela, Luigi Melcarne, Laura Patricia Llovet, Caridad Pontes, Pilar García-Iglesias, Anna Puy, Sergio Lario, Maria Jose Ramirez-Lazaro, Albert Villoria, Johan Burisch, Gilaad G. Kaplan, Xavier Calvet. Economic impact of inflammatory bowel disease in Catalonia: a population-based analysis. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848231222344
|
| 8 |
Yonatan Herman, Firas Rinawi, Benjamin Rothschild, Osnat Nir, Raanan Shamir, Amit Assa. The Characteristics and Long-term Outcomes of Pediatric Crohnʼs Disease Patients with Perianal Disease. Inflammatory Bowel Diseases 2017; 23(9): 1659 doi: 10.1097/MIB.0000000000001171
|
| 9 |
Liming Chen, Xiaolin Zhong, Limin Li, Xue Li, Ya Liu, Chunmei Guo, Yue Chen, Zhanwen Huang. [68Ga]Ga-FAPI-04 PET/CT on assessing Crohn’s disease intestinal lesions. European Journal of Nuclear Medicine and Molecular Imaging 2023; 50(5): 1360 doi: 10.1007/s00259-023-06107-5
|
| 10 |
Wisam SBEIT, Tawfik KHOURY, Anas KADAH, Amir SHAHIN, Asher SHAFRIR, Itai KALISKY, Wadi HAZOU, Lior KATZ, Amir MARI. Nonattendance to gastroenterologist follow-up after discharge is associated with a thirty-days re-admission in patients with inflammatory bowel disease: a multicenter study. Minerva Medica 2021; 112(4) doi: 10.23736/S0026-4806.21.07442-5
|
| 11 |
Grace C. Lovett, Julien D. Schulberg, Amy L. Hamilton, Helen E. Wilding, Michael A. Kamm, Emily K. Wright. Intestinal Ultrasound and MRI for Monitoring Therapeutic Response in Luminal Crohn’s Disease: A Systematic Review. Journal of the American College of Radiology 2024; 21(3): 441 doi: 10.1016/j.jacr.2023.09.010
|
| 12 |
Jacqueline Kolston. Crohn’s Disease: Supporting Patients in Their Pursuit of Disease Control. EMJ Gastroenterology 2016; : 49 doi: 10.33590/emjgastroenterol/10310943
|
| 13 |
Balakrishnan S. Ramakrishna, Govind K. Makharia, Vineet Ahuja, Uday C. Ghoshal, Venkataraman Jayanthi, Benjamin Perakath, Philip Abraham, Deepak K. Bhasin, Shobna J. Bhatia, Gourdas Choudhuri, Sunil Dadhich, Devendra Desai, Bhaba Dev Goswami, Sanjeev K. Issar, Ajay K. Jain, Rakesh Kochhar, Goundappa Loganathan, Sri Prakash Misra, C. Ganesh Pai, Sujoy Pal, Mathew Philip, Anna Pulimood, Amarender S. Puri, Gautam Ray, Shivaram P. Singh, Ajit Sood, Venkatraman Subramanian. Indian Society of Gastroenterology consensus statements on Crohn’s disease in India. Indian Journal of Gastroenterology 2015; 34(1): 3 doi: 10.1007/s12664-015-0539-6
|
| 14 |
Carolina da Silva Beda Sacramento, Marina Pamponet Motta, Candida de Oliveira Alves, Jaciane Araujo Mota, Lina Maria Goes de Codes, Reginaldo Freitas Ferreira, Pedro de Almeida Silva, Larissa do Prado Palmiro, Rafael Miranda Barbosa, Mariana Nery Andrade, Vitor Damasceno Andrade, Vitor Brandão Vasconcelos, Bernardo Wasconcellos Thiara, Eduardo Martins Netto, Genoile Oliveira Santana. Variables associated with progression of moderate-to-severe Crohn’s disease. BMJ Open Gastroenterology 2022; 9(1): e001016 doi: 10.1136/bmjgast-2022-001016
|
| 15 |
Parambir S Dulai, Siddharth Singh, Monica Cesarini, Guillaume Bouguen, Sigrid A Nelson, Laurent Peyrin-Biroulet, Brian G Feagan, Ingrid Ordas, William J Sandborn, Cynthia Santillan, Jordi Rimola, Julian Panes, Geert D'Haens, GY Zou, Jaap Stoker, John K MacDonald, Barrett G Levesque. MRI scoring indices for evaluation of disease activity and severity in Crohn’s disease. Cochrane Database of Systematic Reviews 2015; doi: 10.1002/14651858.CD011630
|
| 16 |
Petra A Golovics, Laszlo Lakatos, Michael D Mandel, Barbara D Lovasz, Zsuzsanna Vegh, Zsuzsanna Kurti, Istvan Szita, Lajos S Kiss, Tunde Pandur, Peter L Lakatos. Prevalence and predictors of hospitalization in Crohn’s disease in a prospective population-based inception cohort from 2000-2012. World Journal of Gastroenterology 2015; 21(23): 7272-7280 doi: 10.3748/wjg.v21.i23.7272
|
| 17 |
Eduard Brunet, Emili Vela, Luigi Melcarne, Montserrat Clèries, Caridad Pontes, Laura Patricia Llovet, Pilar García-Iglesias, Marta Gallach, Albert Villòria, Mercedes Vergara, Xavier Calvet. Time Trends of Crohn’s Disease in Catalonia from 2011 to 2017. Increasing Use of Biologics Correlates with a Reduced Need for Surgery. Journal of Clinical Medicine 2020; 9(9): 2896 doi: 10.3390/jcm9092896
|
| 18 |
Nilofer Husnoo, Tabitha Gana, Adam Gary Hague, Zarnigar Khan, Jenna L. Morgan, Lynda Wyld, Steven R. Brown. Is early bowel resection better than medical therapy for ileocolonic Crohn's disease? A systematic review and meta‐analysis. Colorectal Disease 2023; 25(6): 1090 doi: 10.1111/codi.16502
|
| 19 |
Krzysztof Dąbkowski, Katarzyna Graca-Pakulska, Iwona Zawada, Jerzy Ostrowski, Teresa Starzyńska. Clinical significance of endoscopic findings in the upper gastrointestinal tract in Crohn’s disease. Scandinavian Journal of Gastroenterology 2019; 54(9): 1075 doi: 10.1080/00365521.2019.1656776
|
| 20 |
Michael R. Freund, Ilan Kent, Nir Horesh, Timothy Smith, Steven D. Wexner. Redo ileocolic resection in Crohn's disease – does time passed since previous surgery matter?. Colorectal Disease 2022; 24(4): 484 doi: 10.1111/codi.16035
|
| 21 |
Lieke M Spekhorst, Marijn C Visschedijk, Rinse K Weersma, Eleonora Anna Festen. Down the line from genome-wide association studies in inflammatory bowel disease: the resulting clinical benefits and the outlook for the future. Expert Review of Clinical Immunology 2015; 11(1): 33 doi: 10.1586/1744666X.2015.990439
|
| 22 |
Heike Schmitt, Markus F. Neurath, Raja Atreya. Role of the IL23/IL17 Pathway in Crohn’s Disease. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.622934
|
| 23 |
Chenwen Cai, Sibo Zhu, Jinlu Tong, Tianrong Wang, Qi Feng, Yuqi Qiao, Jun Shen. Relating the transcriptome and microbiome by paired terminal ileal Crohn disease. iScience 2021; 24(6): 102516 doi: 10.1016/j.isci.2021.102516
|
| 24 |
Steven R. Brown. How can the surgeon reduce recurrence after surgery for ileocolic Crohn's disease?. Seminars in Colon and Rectal Surgery 2023; 34(4): 100985 doi: 10.1016/j.scrs.2023.100985
|
| 25 |
Scott A. Strong. The Author Replies. Diseases of the Colon & Rectum 2017; 60(8): e606 doi: 10.1097/DCR.0000000000000865
|
| 26 |
Peter L. Lakatos, Nora Sipeki, Gyorgy Kovacs, Eszter Palyu, Gary L. Norman, Zakera Shums, Petra A. Golovics, Barbara D. Lovasz, Peter Antal-Szalmas, Maria Papp. Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn’s Disease. Journal of Crohn's and Colitis 2015; 9(10): 891 doi: 10.1093/ecco-jcc/jjv127
|
| 27 |
Takahiro Asai, Hiroharu Shinozaki, Satoshi Shinozaki, Akitsugu Makino, Masashi Nakagawa, Kenji Kobayashi, Alan Kawarai Lefor, Seigo Yukisawa, Yoshiro Ogata. The Sasaki-W anastomosis for recurrent Crohn’s disease stenosis after the Kono-S anastomosis. Surgical Case Reports 2023; 9(1) doi: 10.1186/s40792-023-01747-z
|
| 28 |
Amy L Lightner. Segmental Resection versus Total Proctocolectomy for Crohn’s Colitis: What is the Best Operation in the Setting of Medically Refractory Disease or Dysplasia?. Inflammatory Bowel Diseases 2018; 24(3): 532 doi: 10.1093/ibd/izx064
|
| 29 |
Monika A. Krezalek, Lisa M. Cannon, Roger D. Hurst. Inflammatory Bowel Disease. Clinical Gastroenterology 2017; : 289 doi: 10.1007/978-3-319-53763-4_17
|
| 30 |
Stéphane Nahon, Toulsie Ramtohul, Thierry Paupard, Mehdi Belhassan, Emeline Clair, Vered Abitbol. Evolution in clinical presentation of inflammatory bowel disease over time at diagnosis: a multicenter cohort study. European Journal of Gastroenterology & Hepatology 2018; 30(10): 1125 doi: 10.1097/MEG.0000000000001201
|
| 31 |
Christopher A. Lamb, Aamir Saifuddin, Nick Powell, Florian Rieder. The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease. Gastroenterology 2022; 162(5): 1525 doi: 10.1053/j.gastro.2021.09.077
|
| 32 |
Kee Huat Chuah, Raja Affendi Raja Ali, Ida Normiha Hilmi. Decreasing major surgical rates for Crohn’s disease in an emerging economy over two decades: Is it due to biologic therapy?. Indian Journal of Gastroenterology 2020; 39(3): 261 doi: 10.1007/s12664-020-01044-9
|
| 33 |
William J Sandborn, Julian Panés, Silvio Danese, Zaineb Sharafali, Azra Hassanali, Rhian Jacob-Moffatt, Christopher Eden, Marco Daperno, John F Valentine, David Laharie, Carolina Baía, Raja Atreya, Remo Panaccione, Grazyna Rydzewska, Humberto Aguilar, Séverine Vermeire. Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial. The Lancet Gastroenterology & Hepatology 2023; 8(1): 43 doi: 10.1016/S2468-1253(22)00303-X
|
| 34 |
Devendra Desai. Disease Behaviour in Patients with Crohn’s Disease: A Review. Gastroenterology & Hepatology: Open Access 2015; 3(2) doi: 10.15406/ghoa.2015.03.00076
|